Skip to Content

Lumasiran Dosage

Medically reviewed by Drugs.com. Last updated on Jan 12, 2021.

Applies to the following strengths: 94.5 mg/0.5 mL

Usual Adult Dose for:

Usual Pediatric Dose for:

Additional dosage information:

Usual Adult Dose for Primary Hyperoxaluria

At least 20 kg:
-Loading dose: 3 mg/kg subcutaneously once a month for 3 doses
-Maintenance dose: 3 mg/kg subcutaneously every 3 months (quarterly)

Use: For the treatment of primary hyperoxaluria type 1 (PH1) to lower urinary oxalate levels

Usual Pediatric Dose for Primary Hyperoxaluria

Less than 10 kg:
-Loading dose: 6 mg/kg subcutaneously once a month for 3 doses
-Maintenance dose: 3 mg/kg subcutaneously once a month

10 to less than 20 kg:
-Loading dose: 6 mg/kg subcutaneously once a month for 3 doses
-Maintenance dose: 6 mg/kg subcutaneously every 3 months (quarterly)

At least 20 kg:
-Loading dose: 3 mg/kg subcutaneously once a month for 3 doses
-Maintenance dose: 3 mg/kg subcutaneously every 3 months (quarterly)

Use: For the treatment of PH1 to lower urinary oxalate levels

Renal Dose Adjustments

Estimated GFR at least 30 mL/min/1.73 m2: No adjustment recommended.
Estimated GFR less than 30 mL/min/1.73 m2: Data not available

Liver Dose Adjustments

Mild or moderate liver dysfunction: No adjustment recommended.
Severe liver dysfunction: Data not available

Comments:
-Mild liver dysfunction: Total bilirubin greater than the upper limit of normal (ULN) to 1.5 times the ULN (1.5 x ULN) or AST greater than ULN
-Moderate liver dysfunction: Total bilirubin greater than 1.5 to 3 x ULN with any AST
-Severe liver dysfunction: Total bilirubin greater than 3 x ULN with any AST

Precautions

CONTRAINDICATIONS: None

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:
-For subcutaneous use
-Divide injection volumes greater than 1.5 mL equally into multiple syringes.
-Use a sterile 0.3-mL syringe for volumes less than 0.3 mL.
-Administer subcutaneous injection into the abdomen, thigh, or the side/back of the upper arms; rotate injection sites; do not inject into scar tissue or reddened/inflamed/swollen areas.
---If injecting into the abdomen, avoid the area around the navel.
---If more than 1 injection is needed for a single dose, ensure injection sites are at least 2 centimeters apart.
-If dose is delayed/missed, administer as soon as possible; resume prescribed monthly or quarterly dosing from most recently administered dose.

Storage requirements:
-Store at 2C to 25C (36F to 77F).
-Store in original container until ready for use.

General:
-Dosing is based on actual body weight.
-This drug should be administered by a healthcare professional.

More about lumasiran

Consumer resources

Other brands
Oxlumo

Professional resources

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.